SEC Tracker
Get the app

Magenta Therapeutics DNTH

Magenta Therapeutics: signs a material agreement, sells unregistered shares and 4 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
Exhibit 10.4
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Changes shareholder rights (3.03)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Magenta Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Stoke Therapeutics STOK public float $592M, Jun 30, 2025
  2. Trevi Therapeutics TRVI public float $588M, Jun 30, 2025
  3. Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025
  4. Anaptysbio ANAB public float $633M, Dec 31, 2025
  5. Evolus EOLS public float $560M, Jun 30, 2025